Overview

Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for Schizophrenia

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This study will examine whether pretreatment with D-cycloserine before cognitive behavioral therapy can reduce impairments still present in people with stable cases of schizophrenia as well as determine which traits make schizophrenics most likely to respond to D-cycloserine treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Cycloserine